Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies

Rheumatology International

Volumn 28, Issue 2, 2007, Pages 113-119

  Wayaku, Takamasa ^a   Hasegawa, Minoru ^a   Kaji, Kenzo ^a   Kondo, Miki ^a   Saito, Yuki ^a   Orito, Hidemitsu ^a   Horikawa, Mayuka ^a   Matsushita, Takashi ^a   Komura, Kazuhiro ^a   Hayakawa, Ikuko ^a   Hamaguchi, Yasuhito ^a   Ogawa, Fumihide ^b   Fujimoto, Manabu ^a   Takehara, Kazuhiko ^a   Sato, Shinichi ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Anti U1RNP antibody; Histone; Mixed connective tissue disease; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

HISTONE ANTIBODY; HISTONE H1; HISTONE H2A; HISTONE H2B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBONUCLEOPROTEIN ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHROMATIN; COMPARATIVE ANATOMY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTONES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SNRNP CORE PROTEINS; YOUNG ADULT;

EID: 36148936361     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-007-0398-2     Document Type: Article

References (34)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148-159
2. Smolen JS, Steiner G (1998) Mixed connective tissue disease: to be or not to be. Arthritis Rheum 41:768-777
3. Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR (1976) Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systemic lypus erythematosus and other rheumatic diseases. New Eng J Med 295:1149-1154
4. Lemmer JP, Curry NH, Mallory JH, Waller MV (1982) Clinical characteristics and course in patients with high titer anti-RNP antibodies. J Rheumatol 9:536-542
5. Munves EF, Shur PH (1983) Antibodies to Sm and RNP: prognosticators of disease involvement. Arthritis Rheum 26:848-853
6. Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Peltier AP (1978) Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA). Ann Rheum Dis 1978:321-327
7. Reichlin M, Mattioli M (1972) Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. New Eng J Med 286:908-911
8. Reichlin M (1976) Problems in differentiating SLE and mixed connective-tissue disease. New Eng J Med 295:1194-1195
9. Nimelstein SH, Brody S, Mcshane D, Holman HR (1980) Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine 59:239-248
10. Notman DD, Kurata N, Tan EM (1975) Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann Intern Med 83:464-469
11. Lazaro MA, Maldonado Cocco JA, Catoggio LJ, Babini SM, Messina OD, Morteo OG (1989) Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 68:58-65
12. Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J (1989) Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases. Clin Exp Immunol 75:18-24
13. Fritzler MJ, Tan EM (1978) Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest 62:560-567
14. Aitcheson CT, Peebles C, Joslin F, Tan EM (1980) Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen. Arthritis Rheum 23:528-538
15. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 130:1273-1277
16. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31:567-571
17. Kubo M, Ihn H, Yazawa N, Sato S, Kikuchi K, Tamaki K (1999) Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis. J Invest Dermatol 112:711-715
18. Portanova JP, Rubin RL, Joslin FG, Agnello VD, Tan EM (1982) Reactivity of anti-histone antibodies induced by procainamide and hydralazine. Clin Immunol Immunopathol 25:67-79
19. Gohill J, Cary PD, Couppez M, Fritzler MJ (1985) Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol 135:3116-3121
20. Rubin RL, Waga S (1987) Antihistone antibodies in systemic lupus erythematosus. J Rheumatol Suppl 14(Suppl 13):118-126
21. Totoritis MC, Tan EM, McNally EM, Rubin RL (1988) Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med 318:1431-1436
22. Hasegawa M, Sato S, Kikuchi K, Takehara K (1998) Antigen specificity of antihistone antibodies in systemic sclerosis. Ann Rheum Dis 57:470-475
23. Hirakata M, Okano Y, Pati U, Medsger TA Jr, Hardin JA, Craft J (1993) Identification of autoantibodies to RNA polymerase II: occurrence in systemic sclerosis and association with autoantibodies to RNA polymerase I and III. J Clin Invest 91:2665-2672
24. Kasukawa R, Tojo T, Miyawaki S (1987) Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC (eds) Mixed connective tissue diseases and antinuclear antibodies. Elsevier, Amsterdam, pp 41-47
25. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
26. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
27. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Eng J Med 292:403-407
28. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Eng J Med 292:344-348
29. Hardin JA (1986) The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 29:457-460
30. Tan EM (1982) Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 33:167-240
31. Hardin JA, Thomas JO (1983) Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci USA 80:7410-7414
32. Kohda S, Kanayama Y, Okamura M, Amatsu K, Negoro N, Takeda T, Inoue T (1989) Clinical significance of antibodies to histones in systemic lupus erythematosus. J Rheumatol 16:24-28
33. Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach JF, Jacob L (1994) Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:1684-1688
34. Mendelson E, Bustin M (1984) Monoclonal antibodies against distinct determinants of histone H5 bind to chromatin. Biochemistry 23:3459-3466